India�s First mRNA Covid-19 Vaccine by Gennova Biopharmaceuticals Found to be Safe, Gets DGCA Nod fo
[email protected]28 Sep, 2021News
Gennova Biopharmaceuticals Ltd (GBL), the Pune-based biotechnology company working on the nation?s first mRNA-based Covid-19 vaccine submitted the interim clinical data of the Phase-I study to the Central Drugs Standard Control Organisation (CDSCO), the union government?s National Regulatory Authority (NRA).
Related Bookmarks
- Best Alternatives To Zimmer Temporary Abutment In 2021
- Covid-19: India Says Homegrown MRNA Shot Safe In Early Trial
- Few Ways the Fair Debt Collection Act Protects You
- Know How to Repair Your Credit Swiftly
- Leading parties jostle for power in a fragmented Germany
- How Can You Strengthen Your Business With Improved Product Listings?
- Taliban threatening families of Afghan students in UK
- India Approves Further Trials For First Homegrown MRNA COVID-19 Shot
- Lebanese influencer Nathalie Fanj shows off street style at Paris Fashion Week
- How to Add Google Review Widget on Squarespace website?
Recent Profiles
M3m Proparty
Public Relations Agency New York
Masterisehomesland
W88
79king
Timpatcoogan Com Web
Net Vleish
Drejer Mahmoud
Skytte Parrish
Ranumspanat.com